» Authors » Argyrios Tsantes

Argyrios Tsantes

Explore the profile of Argyrios Tsantes including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 12
Citations 99
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Frantzeskaki F, Konstantonis D, Rizos M, Kitsinelis V, Skyllas G, Renieris I, et al.
Diagnostics (Basel) . 2023 Dec; 13(23). PMID: 38066736
Extracorporeal membrane oxygenation (ECMO) is used for the management of severe respiratory and cardiac failure and as a bridge to achieve definite treatment or transplantation. ECMO-associated coagulopathy (EAC) is a...
2.
Asteris P, Kokoris S, Gavriilaki E, Tsoukalas M, Houpas P, Paneta M, et al.
Clin Immunol . 2022 Dec; 246:109218. PMID: 36586431
We aimed to develop a prediction model for intensive care unit (ICU) hospitalization of Coronavirus disease-19 (COVID-19) patients using artificial neural networks (ANN). We assessed 25 laboratory parameters at first...
3.
Flesiopoulou I, Pouliakis A, Politou M, Dourouki A, Damaskos C, Koutsouri T, et al.
Clin Lab . 2020 Jun; 66(6). PMID: 32538044
Background: Red blood cell (RBC) alloantibody titration is a quasi-quantitative method to assess antibody concentration and is considered a useful means of estimating maternal alloimmunization during pregnancy. Traditionally, titration is...
4.
Katsanos A, Krogias C, Lioutas V, Goyal N, Zand R, Sharma V, et al.
J Neurol Sci . 2019 Dec; 409:116628. PMID: 31862517
Although intracerebral hemorrhage (ICH) score is used to provide an estimate on the probability of mortality following spontaneous ICH of any cause, its utility has not been exclusively tested in...
5.
Lioutas V, Goyal N, Katsanos A, Krogias C, Zand R, Sharma V, et al.
J Neurol . 2019 Dec; 267(4):1053-1062. PMID: 31848737
Background: Every anticoagulation decision has in inherent risk of hemorrhage; intracerebral hemorrhage (ICH) is the most devastating hemorrhagic complication. We examined whether combining ischemic and hemorrhagic stroke risk in individual...
6.
Lioutas V, Goyal N, Katsanos A, Krogias C, Zand R, Sharma V, et al.
Ann Clin Transl Neurol . 2019 Aug; 6(8):1546-1551. PMID: 31402613
Prior studies suggest an association between Vitamin K antagonists (VKA) and cerebral microbleeds (CMBs); less is known about nonvitamin K oral anticoagulants (NOACs). In this observational study we describe CMB...
7.
Lioutas V, Goyal N, Katsanos A, Krogias C, Zand R, Sharma V, et al.
Stroke . 2018 Oct; 49(10):2309-2316. PMID: 30355114
Background and Purpose- The aim of this study was to prospectively validate our prior findings of smaller hematoma volume and lesser neurological deficit in nonvitamin K oral anticoagulant (NOAC) compared...
8.
Vrigkou E, Tsangaris I, Bonovas S, Kopterides P, Kyriakou E, Konstantonis D, et al.
Platelets . 2018 Jul; 30(5):646-651. PMID: 30047809
There is a complex and not fully elucidated association between pulmonary arterial hypertension (PAH) and coagulation disorders. The goal of this study was to evaluate platelet function, coagulation and fibrinolysis...
9.
Vrigkou E, Tsangaris I, Bonovas S, Tsantes A, Kopterides P
Crit Care . 2017 Dec; 21(1):329. PMID: 29284527
No abstract available.
10.
Tsivgoulis G, Lioutas V, Varelas P, Katsanos A, Goyal N, Mikulik R, et al.
Neurology . 2017 Aug; 89(11):1142-1151. PMID: 28814457
Objective: To compare the neuroimaging profile and clinical outcomes among patients with intracerebral hemorrhage (ICH) related to use of vitamin K antagonists (VKAs) or direct oral anticoagulants (DOACs) for nonvalvular...